A game-changing PET-CT scan could revolutionize kidney cancer diagnosis! UCLA Health researchers have developed a non-invasive technique that detects clear-cell renal cell carcinoma (ccRCC) with 85.5% accuracy—reducing unnecessary surgeries and improving treatment.
🔬 How it Works:
1. Uses 89Zr-TLX250, a special drug that binds to cancer-specific proteins.
2. “Lights up” kidney tumors on PET-CT scans for clear detection.
3. Successfully tested on 332 patients across 9 countries.
💡 Why It’s a Game-Changer:
1. Detects small tumors (under 2cm) early!
2. Reduces unnecessary surgeries for benign masses.
3. Helps doctors track cancer spread & improve treatments.
🔗 Credit: Research conducted by UCLA Health’s Jonsson Comprehensive Cancer Center. Findings published in The Lancet Oncology.
💬 Do you think AI-powered scans will replace biopsies in the future? Drop your thoughts in the comments!